FOSTER CITY, Calif. -- Sept. 29, 2021-- Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM), a leader in rare liver disease, today announced that the U.S. Food and Drug Administration (FDA) has approved...
Afferent Pharmaceuticals named one of "The Hottest Startups of 2015" by Forbes
News | 01. 05. 2016
Afferent Pharmaceuticals
Afferent Pharmaceuticals named one of "The Hottest Startups of 2015" by Forbes.
